CN109692213A - The drug of chronic heart failure - Google Patents
The drug of chronic heart failure Download PDFInfo
- Publication number
- CN109692213A CN109692213A CN201710989254.4A CN201710989254A CN109692213A CN 109692213 A CN109692213 A CN 109692213A CN 201710989254 A CN201710989254 A CN 201710989254A CN 109692213 A CN109692213 A CN 109692213A
- Authority
- CN
- China
- Prior art keywords
- drug
- heart failure
- chronic heart
- herba
- effects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention discloses a kind of drug of chronic heart failure, consists of the following compositions: cortex albiziae 10g-20g, herba taxilli 15g-30g, Red Psychotria Leaf 5g-8g, scaly holly root 5g-6g, Ilex Latifolia Thunb 12g-15g, strophanthus divaricatus 8g-10g, uncaria 3g-5g, Ke vine 4g-9g, Herba Lycopi 16g-25g and Plumbago zeylanica 1g-3g.The beneficial effects of the present invention are: the effective chronic heart failure of energy, quick, crowd that is without side-effects and being suitable for each age group and different sexes.
Description
Technical field
The invention belongs to drug fields, and in particular to a kind of drug of chronic heart failure.
Background technique
Chronic heart failure is a kind of common, multiple and all age group, healing and its troublesome illness.Currently, also depositing
In the drug of many chronic heart failures, but the not so good and many drug of curative effect can generate certain secondary work mostly
With.With the development of society, these drugs are no longer satisfied disease Man's Demands.
Summary of the invention
The technical problems to be solved by the invention are in view of the above shortcomings of the prior art, to provide and a kind of treat the chronic heart
The drug of force failure, being capable of convenient chronic heart failure and without side-effects.
The technical scheme adopted by the invention is that: a kind of drug of chronic heart failure consists of the following compositions:
Cortex albiziae 10g-20g, herba taxilli 15g-30g, Red Psychotria Leaf 5g-8g, scaly holly root 5g-6g, Ilex Latifolia Thunb 12g-15g, strophanthus divaricatus
8g-10g, uncaria 3g-5g, Ke vine 4g-9g, Herba Lycopi 16g-25g and Plumbago zeylanica 1g-3g.
Preferably, described drug can be made into decoction.
Preferably, described drug can be made into tablet.
Preferably, described drug can be made into capsule.
The beneficial effects of the present invention are: can effective chronic heart failure, it is quick, it is without side-effects and be suitable for
The crowd of each age group and different sexes.
Specific embodiment
Below in conjunction with specific embodiment, invention is further described in detail.
A kind of drug of chronic heart failure, consists of the following compositions:
Cortex albiziae 10g-20g, herba taxilli 15g-30g, Red Psychotria Leaf 5g-8g, scaly holly root 5g-6g, Ilex Latifolia Thunb 12g-15g, strophanthus divaricatus
8g-10g, uncaria 3g-5g, Ke vine 4g-9g, Herba Lycopi 16g-25g and Plumbago zeylanica 1g-3g.
Preferably, described drug can be made into decoction.
Preferably, described drug can be made into tablet.
Preferably, described drug can be made into capsule.
The beneficial effects of the present invention are: can effective chronic heart failure, it is quick, it is without side-effects and be suitable for
The crowd of each age group and different sexes.
Claims (4)
1. a kind of drug of chronic heart failure, it is characterised in that: consist of the following compositions:
Cortex albiziae 10g-20g, herba taxilli 15g-30g, Red Psychotria Leaf 5g-8g, scaly holly root 5g-6g, Ilex Latifolia Thunb 12g-15g, strophanthus divaricatus
8g-10g, uncaria 3g-5g, Ke vine 4g-9g, Herba Lycopi 16g-25g and Plumbago zeylanica 1g-3g.
2. a kind of drug of chronic heart failure according to claim 1, it is characterised in that: described drug can be made
At decoction.
3. a kind of drug of chronic heart failure according to claim 1, it is characterised in that: described drug can be made
At tablet.
4. a kind of drug of chronic heart failure according to claim 1, it is characterised in that: described drug can be made
At capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710989254.4A CN109692213A (en) | 2017-10-22 | 2017-10-22 | The drug of chronic heart failure |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710989254.4A CN109692213A (en) | 2017-10-22 | 2017-10-22 | The drug of chronic heart failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109692213A true CN109692213A (en) | 2019-04-30 |
Family
ID=66225643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710989254.4A Pending CN109692213A (en) | 2017-10-22 | 2017-10-22 | The drug of chronic heart failure |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109692213A (en) |
-
2017
- 2017-10-22 CN CN201710989254.4A patent/CN109692213A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101664428A (en) | Broccoli polyphenol capsules | |
| CN109692213A (en) | The drug of chronic heart failure | |
| CN104758451A (en) | Traditional Chinese medicine composite for treating gout | |
| CN109419918A (en) | A kind of drug for treating hemorrhoid | |
| CN109692237A (en) | The drug for treating coronary heart disease | |
| CN109692244A (en) | A kind of drug for treating primary cardiac myopathy | |
| CN109692215A (en) | A kind of drug for treating alpastic anemia | |
| CN109692280A (en) | A kind of drug for treating myasthenia gravis | |
| CN109419919A (en) | A kind of drug for treating peptic ulcer | |
| CN109692275A (en) | The drug for treating hyperthyroid heart disease | |
| CN109692218A (en) | The drug for treating chronic cor pulmonale | |
| CN109420056A (en) | A kind of drug for treating toothache | |
| CN109692295A (en) | The drug for treating cold | |
| CN109420101A (en) | A kind of drug of systemic lupus erythematosus | |
| CN109692299A (en) | A kind of drug for treating diabetes | |
| CN109692296A (en) | Treat neuralgic drug | |
| CN109692281A (en) | A kind of drug for treating sphagitis | |
| CN109692246A (en) | A kind of drug for treating motor neuron disease | |
| CN109692231A (en) | The drug for treating chronic glomerulonephritis | |
| CN109692287A (en) | The drug for treating dermatitis | |
| CN109692229A (en) | The drug for treating duodenal ulcer | |
| CN109419873A (en) | A kind of drug for treating gastrorrhagia | |
| CN109692260A (en) | A kind of drug for treating primary aldosteronism | |
| CN109419861A (en) | A kind of drug for treating tympanitis | |
| CN109549991A (en) | A kind of drug for treating acute heart failure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190430 |